These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4027515)

  • 1. Chemotherapy before radiotherapy for T3 bladder cancer. A pilot study.
    Kaye SB; MacFarlane JR; McHattie I; Hart AJ
    Br J Urol; 1985 Aug; 57(4):434-7. PubMed ID: 4027515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pilot study of chemotherapy alternating with twice-a-day accelerated radiation therapy as an alternative to cystectomy in muscle infiltrating (stages T2 and T3) cancer of the bladder: preliminary results.
    Vikram B; Malamud S; Silverman P; Hecht H; Grabstald H
    J Urol; 1994 Mar; 151(3):602-4. PubMed ID: 8308967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RTOG 97-06: initial report of a phase I-II trial of selective bladder conservation using TURBT, twice-daily accelerated irradiation sensitized with cisplatin, and adjuvant MCV combination chemotherapy.
    Hagan MP; Winter KA; Kaufman DS; Wajsman Z; Zietman AL; Heney NM; Toonkel LM; Jones CU; Roberts JD; Shipley WU
    Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):665-72. PubMed ID: 14529770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concurrent cisplatin, 5-fluorouracil, leucovorin, and radiotherapy for invasive bladder cancer.
    Chen WC; Liaw CC; Chuang CK; Chen MF; Chen CS; Lin PY; Chang PL; Chu SH; Wu CT; Hong JH
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):726-33. PubMed ID: 12788178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of infiltrating cancer of the bladder with cisplatin, fluorouracil, and concurrent radiotherapy: results of a pilot study].
    Chauvet B; Félix-Faure C; Davin JL; Berger C; Vincent P; Reboul F
    Cancer Radiother; 1998 Apr; 2 Suppl 1():77s-81s. PubMed ID: 9749084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapidly alternating chemotherapy and radiotherapy instead of cystectomy for the treatment of muscle-invasive carcinoma of the urinary bladder: long term results of a pilot study.
    Vikram B; Chadha M; Malamud SC; Hecht H; Grabstald H
    Cancer; 1998 Mar; 82(5):918-22. PubMed ID: 9486582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concurrent platinum and docetaxel chemotherapy and external radical radiotherapy in patients with invasive transitional cell bladder carcinoma. A preliminary report of tolerance and local control.
    Varveris H; Delakas D; Anezinis P; Haldeopoulos D; Mazonakis M; Damilakis J; Metaxaris G; Chondros N; Mavromanolakis E; Daskalopoulos G; Dimitrakopoulos A; Kranidis A
    Anticancer Res; 1997; 17(6D):4771-80. PubMed ID: 9494605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
    George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N
    Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined chemotherapy and radiation with selective organ preservation for muscle-invasive bladder carcinoma. A single-institution phase II study.
    Fellin G; Graffer U; Bolner A; Ambrosini G; Caffo O; Luciani L
    Br J Urol; 1997 Jul; 80(1):44-9. PubMed ID: 9240179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary results in invasive bladder cancer with transurethral resection, neoadjuvant chemotherapy and combined pelvic irradiation plus cisplatin chemotherapy.
    Prout GR; Shipley WU; Kaufman DS; Heney NM; Griffin PP; Althausen AF; Bassil B; Nocks BN; Parkhurst EC; Young HH
    J Urol; 1990 Nov; 144(5):1128-34; discussion 1134-6. PubMed ID: 2122007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Conservative treatment of locally advanced bladder carcinoma: neoadjuvant chemotherapy, TUR and radiotherapy. Results in 40 patients].
    Serretta V; Vasile P; Falletta V; Piazza F; Pavone C; Pavone-Macaluso M
    Arch Ital Urol Androl; 1998 Jun; 70(3 Suppl):37-40. PubMed ID: 9707769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intra-arterial chemotherapy for locally advanced bladder cancer].
    Aota Y; Yoshida K
    Hinyokika Kiyo; 1999 Feb; 45(2):149-53. PubMed ID: 10212791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of cystectomy, and perioperative methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy on the risk and pattern of relapse in patients with muscle invasive bladder cancer.
    Ennis RD; Petrylak DP; Singh P; Bagiella E; O'Toole KM; Benson MC; Olsson CA
    J Urol; 2000 May; 163(5):1413-8. PubMed ID: 10751847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An organ-sparing treatment using combined intra-arterial chemotherapy and radiotherapy for muscle-invading bladder carcinoma.
    Tsukamoto S; Ishikawa S; Tsutsumi M; Nakajima K; Sugahara S
    Scand J Urol Nephrol; 2002; 36(5):339-43. PubMed ID: 12487737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Conservative treatment with chemotherapy and radiotherapy in bladder cancer invading the muscle: preliminary results of a prospective study].
    Zapatero A; Pinar B; Arellano R; López M; Marín A; Jiménez U; Pérez Torrubia A
    Arch Esp Urol; 1997 Jun; 50(5):448-54; discussion 454-6. PubMed ID: 9382586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors in invasive bladder carcinoma in a prospective trial of preoperative adjuvant chemotherapy and radiotherapy.
    Fung CY; Shipley WU; Young RH; Griffin PP; Convery KM; Kaufman DS; Althausen AF; Heney NM; Prout GR
    J Clin Oncol; 1991 Sep; 9(9):1533-42. PubMed ID: 1875217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant interstitial high-dose-rate (HDR) brachytherapy combined with systemic chemotherapy in patients with breast cancer.
    Roddiger SJ; Kolotas C; Filipowicz I; Kurek R; Kuner RP; Martin T; Baltas D; Rogge B; Kontova M; Hoffmann G; Pollow B; Zamboglou N
    Strahlenther Onkol; 2006 Jan; 182(1):22-9. PubMed ID: 16404517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bladder preservation by combined modality therapy for invasive bladder cancer.
    Kachnic LA; Kaufman DS; Heney NM; Althausen AF; Griffin PP; Zietman AL; Shipley WU
    J Clin Oncol; 1997 Mar; 15(3):1022-9. PubMed ID: 9060542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognosis in pT3b infiltrating tumors of the bladder treated by adjuvant chemotherapy].
    Sahwi A; Robert M; Delbos O; Legouffe E; Guiter J; Navratil H
    Prog Urol; 1998 Dec; 8(6):1007-11. PubMed ID: 9894259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Systemic adjuvant chemotherapy of bladder carcinoma with 5 fluorouracil and cyclophosphamide].
    Sbalzarini G; Giuberti AC; Pandolfi C; Del Boca C; Labadini A; Bolognini G
    Minerva Urol Nefrol; 1991; 43(4):273-7. PubMed ID: 1812570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.